Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include sometimes findings: Elevated sweat chloride. 4 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lungs and breathing | 2 | Bronchiectasis, Chronic bronchitis |
SCNN1B function has not been fully characterized.
Bronchiectasis with or without elevated sweat chloride 1 is associated with mutations in the SCNN1B gene on chromosome 16.
Genetic testing for SCNN1B is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for bronchiectasis with or without elevated sweat chloride 1 has been reported in the published literature.
No clinical trials have been registered for bronchiectasis with or without elevated sweat chloride 1.
206 publications have been identified in PubMed for bronchiectasis with or without elevated sweat chloride 1. Research spans Epidemiology / Natural History (30%), Review / Meta-Analysis (30%), and Clinical Trial Publication (13%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 54 | 30% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Program availability and eligibility requirements are set by each foundation. Contact them directly to learn more about your options.
Claim this page and your organization will be listed here for patients and families to find.
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about bronchiectasis with or without elevated sweat chloride 1
Research summaries |
53 |
30% |
Clinical study results | 24 | 13% |
Laboratory research | 20 | 11% |
Other research | 11 | 6% |
Testing and diagnosis research | 11 | 6% |
New treatment approaches | 4 | 2% |
Patient case studies | 2 | 1% |
Omura S (2026). [PMID: 41672947](https://pubmed.ncbi.nlm.nih.gov/41672947/). *Int J Rheum Dis*. [Epidemiology / Natural History]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology*. [Review / Meta-Analysis]
Cazzola M (2026). [PMID: 41712061](https://pubmed.ncbi.nlm.nih.gov/41712061/). *Drugs*. [Review / Meta-Analysis]
Burgel PR (2026). [PMID: 41309268](https://pubmed.ncbi.nlm.nih.gov/41309268/). *The European respiratory journal*. [Gene Therapy / Novel Therapeutics]
Keam SJ (2026). [PMID: 41348269](https://pubmed.ncbi.nlm.nih.gov/41348269/). *Drugs*. [Review / Meta-Analysis]
Cadenas-Jiménez I (2026). [PMID: 41699695](https://pubmed.ncbi.nlm.nih.gov/41699695/). *Respir Res*. [Epidemiology / Natural History]
Mac Aogáin M (2026). [PMID: 41954871](https://pubmed.ncbi.nlm.nih.gov/41954871/). *Drugs*. [Review / Meta-Analysis]
de-Torres JP (2026). [PMID: 41198526](https://pubmed.ncbi.nlm.nih.gov/41198526/). *Arch Bronconeumol*. [Review / Meta-Analysis]
Yu L (2026). [PMID: 41789076](https://pubmed.ncbi.nlm.nih.gov/41789076/). *Front Immunol*. [Review / Meta-Analysis]
Bautista J (2026). [PMID: 41593454](https://pubmed.ncbi.nlm.nih.gov/41593454/). *Current opinion in infectious diseases*. [Clinical Trial Publication]